Cardioverter Defibrillator (CD) is a small device that’s placed in the chest or abdomen or outside. It generates electrical pulses or shocks to help control life-threatening arrhythmias, especially those that can cause sudden cardiac arrest (SCA). SCA is a condition in which the heart abruptly stops beating. If the heart stops beating, blood stops flowing to the brain and other vital organs. SCA usually causes death if it’s not treated within minutes. Thus, the adoption of cardioverter defibrillators is increasing in the high-risk patients with rising incidence & prevalence of various cardiovascular diseases across the globe.
The Cardioverter Defibrillator Devices Market is expected to grow at a CAGR of 4.6% from 2017 to 2022 to reach USD 12,520 million by 2022. Growing need for the devices that are faster, effective, and safer is growing rapidly, which is majorly fueling the growth of the market. Technological advancements, increasing number of cardiac patients, and diagnosis and treatment using non-invasive techniques are some of the major factors driving the growth of the market. However, recurrent product recalls hinders the growth of this market to some extent.
Here are the top 10 companies in Cardioverter Defibrillator market –
Medtronic plc was founded in 1949 and headquartered in Dublin, Ireland. The company designs, manufactures, and sales medical devices. The company offers its products under four operating business segments i.e. cardiac and vascular group, minimally invasive therapies group, restorative therapies group, and diabetes group.
The cardiac and vascular group segment offers, cardioverter defibrillators, cardiac resynchronization therapy devices and implantable cardiac pacemakers. The company has strong geographic presence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa with its 30 subsidiaries across the globe.
Founded in 1979 and headquartered in Massachusetts, U.S.; Boston Scientific Corporation operates in developing, manufacturing, and marketing medical devices for use in various interventional medical specialties worldwide. The company operates into three operating business segments i.e. Cardiovascular, Rhythm Management, and MedSurg.
Cardiovascular segment offers cardiac rhythm management devices, such as implantable cardioverter defibrillator systems and implantable cardiac resynchronization therapy pacemaker systems used to treat & detect abnormally fast heart rhythms & heart failure.
With the strong distribution network and more than 35 subsidiaries including Cardiac Pacemakers, Inc. and Boston Scientific Japan K.K; the company has a strong geographic presence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.
Founded in 1888 and headquartered in Illinois, U.S.; Abbott Laboratories operates in manufacturing & selling health care products worldwide. The company operates in four business segments namely nutritionals products, diagnostics products, established pharmaceutical products, and vascular products.
The vascular segments offer a broad line of coronary, endovascular, vessel closure, and structural heart devices for the treatment of vascular disease that are manufactured, marketed and sold worldwide. The company has strong geographic presence in North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Founded in 1963 and headquartered in Berlin, Germany; BIOTRONIK SE & CO., KG operates in designing, developing, manufacturing, and marketing cardio and endovascular medical devices in Germany and internationally.
The company offers products for bradycardia therapy, including pacemakers, leads, and external devices; tachyarrhythmia therapy, such as ICDs, leads, and external devices; ablation and diagnostic catheters, and temporary pacing for electrophysiology for cardiac resynchronization. The company has a strong geographic presence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.
Sorin Group and Cyberonics are merged together to create a new premier global medical technology company LivaNova PLC in February 2015. Founded earlier in 1987 and headquartered in London, U.K.; LivaNova PLC operates in designing, developing, manufacturing, and selling therapeutic solutions worldwide. The company operates through three business segments namely neuromodulation, cardiac surgery, and cardiac rhythm management. Cardiac Rhythm Management segment offers implantable cardiac pacemakers, cardioverter defibrillators, cardiac resynchronization therapy devices, and patient management tools primarily for electrophysiologists, implanting cardiologists, heart failure specialists, and cardiac surgeons.
With more than 35 subsidiaries including LivaNova Austria GmbH, Cyberonics, Inc., and California Medical Laboratories, Inc.; the company has strong geographic presence in North America, Europe, Asia-pacific, Latin America, and Middle East & Africa.
“Meticulous Research in its latest publication on Cardioverter Defibrillator Market has predicted the growth of 10.0% during the forecast year 2018-2023″.
Founded in 1955 and headquartered in Washington, U.S.; Physio-Control, Inc. is engaged in development, manufacture, sale and service of external defibrillator/monitors and emergency medical response products and services. The Company offers prehospital products, such as video laryngoscopes, monitor/defibrillators, CPR devices, data solutions, and AEDs.
Stryker Corporation has acquired Physio-Control, Inc. from Medtronic plc in April 2016. Since then Physio-Control is operating as a wholly owned subsidiary of Stryker Corporation. The company has a strong geographic presence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.
Founded in 1891 and headquartered in Amsterdam, Netherlands; Koninklijke Philips N.V. operates as a health technology company worldwide. The Company operates through five reporting business segments namely Personel Health, Lighting, Diagnostic & Treatment, Connected care & Health informatics, and Healthtech Other. The Connected care & Health informatics segment offers emergency care and resuscitation solutions and products which include automated external defibrillators, AED software, and other related accessories.
With more than 50 subsidiaries, the company has strong geographic presence across the world including strong revenue from U.S., China, Germany, Japan, France, India, and the Netherlands.
Founded in 1951 and headquartered in Tokyo, Japan; Nihon Kohden Corporation operates in developing, manufacturing, sales, maintenance, and consultation of medical electronic equipment, related systems, and products.
The company operates in three business segments, namely Physiological Measuring Equipment, Patient Monitors, and Treatment Equipment and others. The treatment equipment segment offers defibrillators, AEDs, pacemakers, vagal nerve stimulators, and anesthesia machine.
With more than 10 subsidiaries, the company has a strong geographic presence in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
Established in 1991 and headquartered in Trofarello, Italy; Progetti Srl engaged in developing products for the prevention and treatment of heart diseases. The Company offers its products in four segments, namely emergency, diagnostics, intensive care, and operating theatre. The intensive care and emergency segment offers a range of defibrillators and associated devices.
The company has a strong geographic presence in more than 60 countries all over the world.
Founded in 1948 and headquartered in Tokyo, Japan; Fukuda Denshi Co., Ltd. operates in developing, manufacturing, and selling medical electronic equipment worldwide. The Company offers its products through four business segments, namely Physiological Diagnostic Equipment, Patient Monitoring Equipment, Medical Treatment Equipment, and Consumables & other products.
Popular Mentions- Schiller AG (Switzerland), Cardiac Science Corporation (U.S.), and ZOLL Medical Corporation (U.S.)
Authoritative Research on the Cardioverter Defibrillator Devices Market – Global Opportunity Analysis and Industry Forecast 2022
Meticulous Research®’s new report covers each of these companies in much more detail, providing analysis on the following:
Cardioverter-Defibrillator Devices Market by Product:
- Implantable cardioverter defibrillator
- Transvenous cardioverter defibrillator
- Single-chamber cardioverter defibrillator
- Dual-chamber cardioverter defibrillator
- CRT-Ds/Biventricular cardioverter defibrillator
- Subcutaneous cardioverter defibrillator
- Transvenous cardioverter defibrillator
- External cardioverter defibrillator
- Manual external cardioverter defibrillator
- Automated external cardioverter defibrillator
- Fully-automated cardioverter defibrillator
- Semi-automated cardioverter defibrillator
- Wearable external cardioverter defibrillator
Cardioverter-Defibrillator Devices Market by End-user:
- Ambulatory surgery centre
Cardioverter-Defibrillator Devices Market by Geography:
- North America
- Rest of Europe
- Rest of Asia-Pacific
- Rest of World
- Latin America
- Middle East and Africa
Key questions answered in the report:
Increasing prevalence of cardiovascular diseases and related diseases such as hypertension, and diabetes to drive the adoption of cardioverter defibrillator devices market
- How does the penetration of implantable cardioverter defibrillator in medical devices industry differ from the penetration of external cardioverter defibrillator?
- Which are the high growth market segments in terms of product type, and regions/countries?
The North American cardioverter defibrillator devices market favors both larger and local manufacturers that compete in multiple segments
- Who are the top competitors in this market and what strategies do they employ to gain shares?
- What is driving the growth and which market segments have the most potential for revenue expansion over the forecast period?
- What strategies should new companies looking to enter this market use to compete effectively?
- What are the major drivers, restrains, and opportunities in the global cardioverter defibrillator devices market?
- Who are the major players in various countries and what share of the market do they hold?
- What are the geographical trends and high growth regions/ countries?
Recent new approvals, collaborations, partnerships, and agreements, new product launch, and expansions taken place in the cardioverter defibrillator devices space.
- What companies have recently partnerships/collaborations/agreements and how will these unions affect the competitive landscape of the Implantable cardioverter defibrillator space?
- Which companies have recently received approvals and how will these approvals promote a competitive advantage?
- Who are the major players in the global cardioverter defibrillator devices market and what share of the market do they hold?
- Who are the local emerging players in the global cardioverter defibrillator devices market and how do they compete with the global players?
Comprehensive report provides global market size estimates, market share analysis, revenue numbers, and coverage of key issues and trends.
Need more , Please download report pages and learn more: https://www.meticulousresearch.com/download-sample-report/cp_id=3596